Published in Gene Therapy Weekly, August 10th, 2000
In the study, immune-deficient mice were transplanted with human breast cancer and then treated with Genasense, either alone or with doxorubicin. Whereas the individual agents showed only modest activity when used alone, the two-drug combination yielded highly synergistic antitumor activity.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.